MEDPACE HOLDINGS INC. 2024-2025 Proxy Voting Records

Description as filed by funds: Election of Directors: August J. Troendle

MEDPACE HOLDINGS INC.’s own tally for this item (“Elect Director: August J. Troendle”): 21,156,998 for, 5,128,383 withheld, per its Form 8-K filed May 16, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “(b) Stockholders voted on the matters set forth below: Proposal 1 — Election of Directors The following nominees were elected to the Company's Board of Directors to serve as Class III Directors until the Company's 2026 Annual Meeting of Stockholders based upon the following votes:”
Support: 80% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 127 asset managers below reported 7,538,928 for, 1,098,706 withheld, 206,083 abstained, 57 not voted.

Showing the 25 largest of 127 asset managers. See all 127 in the interactive database.

Description as filed by funds: Election of Directors: Dani S. Zander

MEDPACE HOLDINGS INC.’s own tally for this item (“Elect Director: Dani S. Zander”): 25,858,694 for, 426,687 withheld, per its Form 8-K filed May 16, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “(b) Stockholders voted on the matters set forth below: Proposal 1 — Election of Directors The following nominees were elected to the Company's Board of Directors to serve as Class III Directors until the Company's 2026 Annual Meeting of Stockholders based upon the following votes:”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 127 asset managers below reported 8,836,584 for, 5,844 withheld, 1,289 abstained, 57 not voted.

Showing the 25 largest of 127 asset managers. See all 127 in the interactive database.

Description as filed by funds: To approve the Medpace Holdings, Inc. 2016 Amended and Restated Incentive Award Plan.

MEDPACE HOLDINGS INC.’s own tally for this item (“4. Approval of the Company's 2016 Amended and Restated Incentive Award Plan The proposal to approve the Company's 2016 Amended and Restated Incentive Award Plan”): 25,567,981 for, 702,406 against — passed, per its Form 8-K filed May 16, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 4 —Approval of the Company's 2016 Amended and Restated Incentive Award Plan The proposal to approve the Company's 2016 Amended and Restated Incentive Award Plan was approved based upon the following votes:”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of MEDPACE HOLDINGS INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Amend Omnibus Stock Plan” (7 managers, Fund and manager reports combined; may count the same shares twice; no share total shown); “Amend Stock Option Plan” (2 managers, 1,800 for, 13 unknown).

The 130 asset managers below reported 8,902,384 for, 23,757 against, 4,831 abstained, 57 not voted.

Showing the 25 largest of 130 asset managers. See all 130 in the interactive database.

Description as filed by funds: To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy statement for the 2025 Annual Meeting.

MEDPACE HOLDINGS INC.’s own tally for this item (“3. Advisory Vote on the Compensation of our Named Executive Officers The proposal to approve, on an advisory basis, the compensation of the Company's Named Executive Officers”): 24,918,234 for, 1,340,033 against — passed, per its Form 8-K filed May 16, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 3 — Advisory Vote on the Compensation of our Named Executive Officers The proposal to approve, on an advisory basis, the compensation of the Company's Named Executive Officers was approved based upon the following votes:”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of MEDPACE HOLDINGS INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Advisory Vote to Ratify Named Executive Officers' Compensation” (29 managers, Fund and manager reports combined; may count the same shares twice; no share total shown); “To approve, on an advisory basis, the H of our named executive officers as disclosed in the proxy statement for the 2025 Annual Meeting.” (2 managers, 75,538 for).

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 123 managers: 8,801,151 for, 47,833 against, 4,831 abstained, 57 not voted. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 432 managers: 14,030,345 for, 1,009,137 against, 10,000 abstained, 2,094 not voted, 201,929 mixed. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.

MEDPACE HOLDINGS INC.’s own tally for this item (“2. Ratification of Appointment of Independent Registered Public Accounting Firm The appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December ”): 27,200,285 for, 600,429 against — passed, per its Form 8-K filed May 16, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 2 — Ratification of Appointment of Independent Registered Public Accounting Firm The appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 was ratified based upon the following votes:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 130 asset managers below reported 8,881,131 for, 65,322 against, 4,831 abstained, 57 not voted.

Showing the 25 largest of 130 asset managers. See all 130 in the interactive database.

Description as filed by funds: Stockholder proposal regarding implementation of simple majority voting, if properly presented at the meeting.

MEDPACE HOLDINGS INC.’s own tally for this item (“5. Advisory Vote on Stockholder Proposal The non-binding advisory stockholder proposal regarding simple majority voting”): 18,210,462 for, 8,021,457 against — passed, per its Form 8-K filed May 16, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 5 — Advisory Vote on Stockholder Proposal The non-binding advisory stockholder proposal regarding simple majority voting was approved based upon the following votes:”
Support: 69% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 129 asset managers below reported 8,169,705 for, 769,508 against, 5,440 withheld, 4,831 abstained, 57 not voted.

Showing the 25 largest of 129 asset managers. See all 129 in the interactive database.